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Comparative genomics of 
Mycobacterium africanum Lineage 5 
and Lineage 6 from Ghana suggests 
distinct ecological niches
Isaac Darko Otchere  1,2, Mireia Coscollá3,4, Leonor Sánchez-Busó  5, Adwoa Asante-Poku  1, 
Daniela Brites3,4, Chloe Loiseau3,4, Conor Meehan6, Stephen Osei-Wusu1, Audrey Forson7, 
Clement Laryea8, Abdallah Iddrisu Yahayah9, Akosua Baddoo7, Gloria Akosua Ansa10, 
Samuel Yaw Aboagye1, Prince Asare1, Sonia Borrell3,4, Florian Gehre6,11, Patrick Beckert12,13, 
Thomas A. Kohl12,13, Sanoussi N’dira14, Christian Beisel15, Martin Antonio11,16, 
Stefan Niemann12,13, Bouke C. de Jong6,11, Julian Parkhill  5, Simon R. Harris  5, 
Sebastien Gagneux3,4 & Dorothy Yeboah-Manu1
Mycobacterium africanum (Maf) causes a substantial proportion of human tuberculosis in some 
countries of West Africa, but little is known on this pathogen. We compared the genomes of 253 Maf 
clinical isolates from Ghana, including N = 175 Lineage 5 (L5) and N = 78 Lineage 6 (L6). We found that 
the genomic diversity of L6 was higher than in L5 despite the smaller sample size. Regulatory proteins 
appeared to evolve neutrally in L5 but under purifying selection in L6. Even though over 90% of the 
human T cell epitopes were conserved in both lineages, L6 showed a higher ratio of non-synonymous to 
synonymous single nucleotide variation in these epitopes overall compared to L5. Of the 10% human T 
cell epitopes that were variable, most carried mutations that were lineage-specific. Our findings indicate 
that Maf L5 and L6 differ in some of their population genomic characteristics, possibly reflecting 
different selection pressures linked to distinct ecological niches.
The global phylogeography of the human-adapted Mycobacterium tuberculosis complex (MTBC) shows highest 
diversity in West Africa, with six out of the seven known lineages represented1,2. Two of these lineages, Lineage 
5 (L5) and Lineage 6 (L6), together originally known as Mycobacterium africanum (Maf), are restricted to West 
Africa for unknown reasons. By contrast, MTBC lineages belonging to Mycobacterium tuberculosis sensu stricto 
(Mtbss), in particular Lineage 4 (L4), are more geographically widespread1. M. africanum has remained an impor-
tant pathogen in West Africa since its first description in 19683, and is responsible for up to half of human tuber-
culosis (TB) in some regions4.
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The MTBC is thought to have originally emerged in Africa and subsequently spread to other parts of the world 
following waves of human migrations, trade and conquests5–8. Yet the reason(s) why Maf is limited to West Africa 
despite, for example, centuries of the trans-Atlantic slave trade remains unknown. Some comparative studies 
have identified phenotypic differences between the two Maf lineages9,10, suggesting they might be fundamentally 
distinct and occupy different ecological niches.
Three hypotheses have been put forward to explain the restriction of Maf to West Africa. The first hypothesis 
proposes that Maf might have emigrated outside of Africa but was later outcompeted by Mtbss, which has been 
shown to be more virulent than Maf in animal models11. The second hypothesis states that the restriction of Maf 
to West Africa is due to its adaptation to West African human populations9,12. Finally, according to the third 
hypothesis, Maf might be zoonotic with an animal reservoir restricted to West Africa.
Some evidence in support of the first hypothesis is the reported association of Maf (L6) with HIV co-infection, 
attenuated ESAT-6 responses and delayed progression to active disease relative to Mtbss9,13–16. In addition, both 
Maf lineages as well as Mtbss L1, together described as “ancestral” MTBC lineages, have been shown to elicit a 
stronger early production of pro-inflammatory cytokines compared to the “modern” MTBC L2, L3 and L417. 
The delayed pro-inflammatory immune response in the “modern” MTBC lineages might allow for more rapid 
disease progression and transmission17. The second hypothesis is supported by the statistical association of L5 
with the native West African ethnic group known as “Ewe” reported by two independent studies in Ghana9,12. 
The third hypothesis is mainly supported by the phylogenetic placement of Maf (L6) amidst the cluster of the 
animal-adapted members of the MTBC in the various phylogenies of the MTBC5,7,18.
If the first hypothesis is true, the proportion of Maf associated TB in West Africa is expected to decline over 
time. However, there are conflicting reports of the proportion of Maf associated TB in West Africa. Even though 
the report of a steady decline of Maf associated TB in some settings seems to support the first hypothesis19–21, 
other studies indicate that Maf remains an important cause of TB in West-Africa22–24. In Ghana for instance, a 
recent study showed that the proportion of TB due to Maf remained constant over the 8 year study period25. Even 
though, the reported statistical association of L5 with ethnicity in Ghana suggests a possible co-evolutionary sce-
nario in favour of the second hypothesis, genetic evidence of co-evolution/co-adaptation remains to be demon-
strated. In the case of the third hypothesis, the environmental or zoonotic reservoir(s) need to be identified.
In this study, we used whole genome sequencing of Ghanaian Maf clinical strains to explore population 
genomic differences between the two Maf lineages that might support one or more of these hypotheses.
Results
Whole genome SNP distance, average nucleotide diversity and phylogeny of Maf in Ghana. 
Our data set comprised Maf isolates obtained from TB patients reporting to various hospitals in Ghana. After 
excluding genomes that did not meet the quality criteria (Supplementary Fig. S1), 253 Maf genomes (175 L5 and 
78 L6) were used for the analysis. Patients’ residential regions are provided (Supplementary Fig. S2). The upper 
right pie chart indicates those 97 patients (55 infected with L5 and 42 with L6) with no information on region of 
residence. We found the number of fixed SNPs (SNPs found in more than 95% of genomes) to be significantly 
higher in L6 (Median = 1,037) compared to L5 (Median = 928) (Wilcoxon rank-sum test, p < 0.0001) (Fig. 1a). 
Moreover, despite the larger number of L5 genomes (more than twice the number of L6 genomes) analyzed, the 
mean pairwise SNP distance between any two strains was significantly higher in L6 (360) compared to L5 (223) 
(Wilcoxon rank-sum test, p < 0.0001; Fig. 1b). Finally, the whole genome average nucleotide diversity (π) for L6 
(0.000110) was significantly higher compared to L5 (0.00007) (Fig. 1c, non-overlapping 95% confidence interval 
(CI)). Taken together, these findings show that L6 in Ghana is significantly more genetically diverse than L5 irre-
spective of sample size. The whole genome-based phylogenetic tree of the Ghanaian Maf strains generated from 
11,027 total polymorphic positions is shown in Fig. 2. The Maf lineages were resolved as two distinct branches of 
the genome-based tree with possible sub-groups (Fig. 2).
Genetic diversity of L6 is significantly higher than L5 among T cell epitopes and genes of other 
functional categories. We found that the higher diversity of L6 compared to L5 was reflected across all the 
8 functional categories of genes analyzed (Fig. 3). Whereas pairwise nucleotide diversity (π) for L5 was below 
0.0001 across all functional categories, the estimates for L6 were all above 0.0001. The most prominent difference 
between L6 and L5 was within 1,226 experimentally confirmed human T cell epitopes of MTBC which we down-
loaded from the Immune Epitope Database (IEDB)26, for which the mean π for L5 was 0.000063 compared to 
the 0.000149 estimated for L6, reflecting more than a two-fold difference in diversity (non-overlapping 95% CI).
Within L5, there was no difference between the estimated π for the T cell epitopes and any of the other func-
tionally categorized genes. However, within L6, genes encoding regulatory proteins and those involved with 
virulence, detoxification and adaptation were more diverse compared to those for lipid metabolism as well as 
intermediate metabolism and respiration (non-overlapping 95% CI). In addition, genes encoding regulatory pro-
teins were more diverse compared to those involved with lipid metabolism (non-overlapping 95% CI).
Different selection pressures within L5 and L6 in human T cell epitopes and regulatory proteins. 
The mean pairwise dN/dS of the concatenates of T cell epitopes as well as genes of the seven other functional 
categories were calculated for all genomes and compared between L5 and L6. Apart from sequences encoding 
human T cell epitopes and regulatory proteins that had median mean pairwise dN/dS ratios greater than 1.0 in L6 
and L5, respectively (Fig. 4, panel a and b), all the remaining functional categories showed a dN/dS ratio of less 
than 1.0 in both lineages (Supplementary Fig. S3). Human T cell epitopes of Maf L5 (median mean pairwise dN/
dS = 0.64) were significantly more conserved compared to L6, which exhibited higher diversity (median mean 
pairwise dN/dS = 1.53) (Wilcoxon rank-sum test, W = 2265, p < 0.0001). Conversely, genes encoding regulatory 
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Figure 1. Whole genome diversity of Maf Lineages (175 L5 and 78 L6 genomes). (a) Number of SNPs between 
Maf genomes and the hypothetical MTBC ancestor (the median fixed SNPs of L5 (934) is lower (W = 417, 
p-value < 2.2e-16) compared to L6 (1,039). (b) Pairwise SNPs between genomes within each lineage (the 
median of the pairwise SNPs is lower (W = 234, p-value < 2.2e-16) in L5 (212) compared to L6 (334). (c) Whole 
genome average nucleotide diversity (π) between L5 and L6 (the mean diversity of L5 (0.000076) is significantly 
(non-overlapping 95% confidence intervals) lower than L6 (0.000110). Error bars indicate 95% confidence 
intervals.
Figure 2. Phylogeny of Ghanaian Maf strains. The maximum likelihood phylogenetic tree of 253 Ghanaian 
Maf isolates is based on 11,027 variable positions. The tree was rooted on M. canettii and the confidence of 
nodes was assessed by bootstrapping 1000 pseudo replicates. Each lineage clade is colored according to the 
conventional MTBC lineage color codes1.
www.nature.com/scientificreports/
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proteins were more diverse among L5 genomes (with median mean pairwise dN/dS = 1.03) (Wilcoxon rank-sum 
test, W = 6303, p = 0.0010) compared to L6 (with median mean pairwise dN/dS = 0.85). To account for the dif-
ferent sample sizes; 147 L5 compared to 67 L6 genomes after excluding 43 genomes differing from others with less 
than 10 SNPs difference (see Methods and Supplementary Fig. S1), we repeated the analysis using mean values 
of 10 randomly sampled sets of L5 genomes with sample size 67 among human T cell epitopes (Fig. 4, panel c) 
and regulatory proteins (Fig. 4 panel d) and got similar results (Wilcoxon rank-sum test, W = 1300, p < 0.0001, 
W = 3466, p < 0.0001 for T cell epitopes and regulatory proteins, respectively).
Lineage-specific accumulation of mutations within human T cell epitopes. When we compared 
the number of epitopes with amino acid mutations between lineages, we found more epitopes mutated in L6 
(N = 57) compared to L5 (N = 45), but this difference was not statistically significant (Fig. 5). In addition, we 
compared the number of nonsynonymous polymorphic sites between the two Maf lineages within the human 
T cell epitopes (Supplementary Fig S4), and found there were more frequent in L6 (N = 38) compared to L5 
Figure 3. Averaged nucleotide diversity (π) of Maf within genes of eight functional categories. epit – genes 
encoding human T cell epitopes, esmac – genes essential for growth in macrophages, intmedres – genes involved 
with intermediate metabolism and respiration, lipmet – genes involved with lipid metabolism, virdetad – 
genes involved with virulence, detoxification and adaptation, cwallproc - genes involed with cell wall and 
cell processes, regprot – genes encoding regulatory proteins and infopath – genes involved with information 
pathways. Error bars are indications of 95% confidence intervals.
Figure 4. Pairwise dN/dS of genes encoding human T cell epitopes and regulatory proteins in L5 and L6. 
Estimation of pairwise dN/dS of epitopes (a) and regulatory proteins (b) using the entire 147 L5 against the 67 
L6 genomes. Estimation of pairwise dN/dS of epitopes (c) and regulatory proteins (d) using the mean dN/dS 
values of 10 random samples (size = 67, with replacement) of L5 against the 67 L6 genomes.
www.nature.com/scientificreports/
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(N = 28) but with no statistically significant difference between L5 and L6 (X2 = 0.0055, p-value = 0.9407). We 
compared the identity of the mutant human T cell epitopes between the two Maf lineages (Fig. 6a) and found 
72 epitopes that were uniquely mutated in L5 (among 174 genomes) compared to 54 epitopes in L6 (among 
67 genomes). Only two epitopes (IEDB IDs 178644 and 178609) were mutated in both lineages. However, the 
mutations were at different loci with different amino acid substitutions (A183G and G278D in L5 compared to 
A177V and D277N in L6). In terms of T cell antigens, there were 28 uniquely mutated in L5 compared to 19 in 
L6 and 12 mutated in both lineages involving different epitopes within the respective antigens (Fig. 6b). The 12 T 
Figure 5. Number of human T cell epitopes with nonsynonymous SNPs (nsSNPs) stratified by Maf lineage. No 
significant difference (X-squared = 1.487, df = 1, p-value = 0.22) between the number of epitopes with nsSNPs 
among the 67 L6 genomes and L5 (mean values of 10 random samples of size = 67 with replacement).
Figure 6. Number of human T cell epitopes (a) and human T cell antigens (b) with amino acid substitutions 
stratified by Maf lineage. Green represents L6-specific mutant antigens or epitopes. Brown represents L5-
specific mutant antigens or epitopes. Yellow represents antigens or epitopes mutated in both L5 and L6 but at 
different loci with different amino acid substitutions.
www.nature.com/scientificreports/
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cell antigens mutated in both lineages are summarized in Table 1. All T cell epitopes and antigens with mutations 
among the two Maf lineages are listed in Supplementary Table S5.
Conservation of human T cell epitopes of L5 is not affected by patient ethnicity. We previously 
reported an association between L5 and Ewe patient ethnicity9,12. Hence to test if conservation of T cell epitopes 
and/or the diversity of regulatory proteins in L5 was influenced by patient ethnicity, we estimated pairwise dN/
dS for sequences encoding T cell epitopes and regulatory proteins of L5 genomes stratified by patient ethnic-
ity (Fig. 7). The median dN/dS of T cell epitopes were all below 1.0 irrespective of patient ethnicity (Fig. 7a). 
However, the median dN/dS of regulatory proteins were marginally above 1.0 among L5 from Ewe TB patients 
and below 1.0 among L5 from non-Ewe TB patients (Fig. 7b). There was no statistically significant difference 
between the estimated dN/dS of either the sequences encoding T cell epitopes (Fig. 7a) or regulatory proteins 
(Fig. 7b) between L5 from TB patients of Ewe and non-Ewe ethnicities. In addition, there was no difference in 
either the number of T cell epitopes with amino acid substitutions (Supplementary Fig. S6A) or the number of 
non-redundant SNPs (Supplementary Fig. S6B) between L5 strains from patients of the Ewe ethnicity and those 
of other ethnicities.
T cell antigen Function
Rv0288 encodes low molecular weight antigen 7 EsxH involved with cell wall and cell processes
Rv0934 encodes periplasmic phosphate-binding lipoprotein PstS1 involved with cell wall and cell processes
Rv2029c encodes 6-phosphofructokinase PfkB involved with intermediate metabolism and respiration
Rv2627c encoding a conserved hypothetical protein
Rv3003c Encodes the large subunit of acetolactate synthase involved with valine and isoleucine biosynthesis
Rv3024c encodes a probable tRNA involved with information pathways
Rv3763 encodes a 19 kDa lipoprotein antigen precursor LpqH involved with cell wall and cell processes
Rv3804c encodes the secreted antigen 85-a FbpA involved with lipid metabolism
Rv3823c encodes conserved integral membrane transport protein MmpL8 involved with cell wall and cell processes
Rv3825c encodes polyketide synthase Pks2 involved with lipid metabolism
Rv3879c encodes ESX-1 secretion-associated protein EspK involved with cell wall and cell processes
Rv3883c encodes membrane-anchored myosin MycP1 involved with intermediate metabolism and respiration
Table 1. Functions of the 12 T cell antigens mutated in both L5 and L6.
Figure 7. Pairwise dN/dS of sequences encoding human T cell epitopes (a) and genes encoding regulatory 
proteins (b) of L5 by patient ethnicity. L5 genomes from strains isolated from patients of the Ewe ethnicity (15 
genomes) against, average values of 10 random samples of size 15 of L5 genomes of isolates from Non-Ewe 
patients.
www.nature.com/scientificreports/
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Discussion
In this study, we analysed the largest collection of Maf genomes including both L5 and L6 reported so far. We 
found that (1) at the whole genome level, L6 had significantly higher pairwise nucleotide diversity, higher number 
of fixed SNPs as well as higher average pairwise SNPs relative to L5, (2) L6 had overall more diverse human T cell 
epitopes compared to L5, (3) the conservation of T cell epitopes in L5 was not influenced by patient ethnicity, 
and (4) genes encoding regulatory proteins of L5 had lower pairwise nucleotide diversity but a higher ratio of 
non-synonymous to synonymous substitution rate than L6.
Our finding that Maf L6 has a higher genetic diversity relative to L5 suggests that L6 has diversified more 
compared to L5 since the emergence of the two lineages5,27,28. The higher diversity of L6 could be due to either an 
earlier emergence, a higher mutation rate or both compared to L5. Our whole genome-based phylogenies rooted 
on Mycobacterium canettii showed that following the branch leading to Maf and all animal-adapted members of 
the MTBC defined by the characteristic deletion in RD929,30, L5 branches off earlier than L631. This designates 
L5 as basal to L6, hence arguing against the possibility of the higher diversity of L6 being primarily the result of 
earlier emergence. This notion is also supported by genomic deletion analyses showing that in addition to the 
deletion in RD9, L6 and all the animal-adapted members of the MTBC harbor the deletions of RD7, RD8 and 
RD1029. Therefore, higher intrinsic mutation rate and/or other factors are more likely to account for the higher 
diversity of L6 compared to L5 in Ghana.
Maf is highly restricted to West Africa, and thus could be seen as an ecological specialist compared to the other 
MTBC lineages. Specialists are expected to harbour less diversity across strains compared to generalists8. The 
observed lower genome-wide nucleotide diversity of L5 hence supports the hypothesis that L5 might be a special-
ist maintained in West Africa by adaptation to specific human genotypes9,12. In contrast, the higher genome-wide 
diversity of L6 indicates a generalist pathogen, and hence would have been expected to be globally distributed 
instead of displaying restriction to West Africa4,8. The observed diversity of L6 therefore may indicate a pathogen 
with a wider host range, supporting the hypothesis of maintenance in West Africa by possible environmental or 
zoonotic reservoir(s). Alternatively, it is also possible that the lower diversity of L5 observed relative to L6 could 
be due to a clonal expansion following a single introduction. Further studies comparing L5 and L6 from different 
countries in West Africa will help distinguish between these different possibilities.
Even though over 90% of T cell epitopes were conserved in both L5 and L6 (Fig. 5), which is in line with previ-
ous reports for the whole MTBC8,32,33, we found T cell epitopes in L6 overall to exhibit higher nucleotide diversity 
and a higher nonsynonymous to synonymous ratio compared to L5. The purifying selection of mutations within 
L5 is comparable to that reported for the specialist sub-lineages of L48. Interestingly, dN/dS within essential genes 
for survival in macrophages did not differ between L5 and L6 (Supplementary Fig. S3) supporting the notion 
that the genes in this category perform key functions in both L5 and L6. Since T cell responses partially drive 
the pathogenesis of TB34, the relative conservation of T cell epitopes in L5 indicate that it might elicit a more effi-
cient T cell response compared to L6 in its particular host population. This therefore suggests L5 may be a more 
human-specific pathogen and L6, with significantly more diverse T cell epitopes, a potential opportunistic envi-
ronmental or zoonotic pathogen. Even though the conserved T cell epitopes of L5 could account for geographical 
restriction to West Africa and the association with the Ewe ethnicity1,4,9,12, we found no difference between the 
diversity of L5 isolated from TB patients of Ewe and those of non-Ewe ethnic backgrounds. The limited number 
of L5 genomes from Ewe TB patients could possibly account for the lack of observed difference in diversity of T 
cell epitopes of L5 from TB patients of Ewe and non-Ewe ethnicities, and hence larger sample sizes are required 
to explore this further. L5 isolated from TB patients of the Ewe ethnicity were shown to be randomly distributed 
across the L5 clade of the Maf phylogeny instead of clustering in a particular sub-clade (Supplementary Fig. S7). 
This suggests that, if L5 is indeed maintained in West Africa by its co-evolution/adaptation with the Ewe ethnic 
group of West Africa (Cote d’Ivoire, Ghana, Nigeria, Togo and Benin)9,12, there is no specific sub-group of L5 that 
is responsible for this association but rather the whole of L5.
Members of the MTBC survive in the host mostly by modulation of the host immune response via the action 
of secretory proteins which form part of regulons controlled by specific regulatory proteins35,36. In addition, some 
regulatory proteins are involved in the regulation of transcription and translation of these secretory effectors as 
well as gene expression of other proteins involved with diverse functions36,37. Regulatory proteins in the MTBC 
hence play an important role in the survival and propagation of the bacteria. Therefore, our finding that regu-
latory proteins in L5 are under neutral selection (dN/dS = 1.03) compared to L6 in which they appear under 
purifying selection indicates that the mutations within regulatory proteins might be lineage-specific. This result 
is comparable to an earlier report comparing mutations within regulatory proteins between Mtbss and M. bovis, 
which found M. bovis to harbor majority of the mutations36. As mutations within some regulatory proteins have 
been associated with attenuated virulence38–40, our observation could account for the reported attenuated viru-
lence of Maf relative to Mtbss14,15,17,41. This calls for further comparative studies of regulatory proteins between L5, 
L6 and other MTBC lineages to ascertain the effects of variation in regulatory proteins.
Our data is limited by the fact that, the number of L5 genomes was almost 3 times the number of L6 genomes; 
however, we used 1,000x bootstrap sampling with replacement of both L5 and L6 of equal sample size to limit any 
possible bias when comparing both lineages due to differences in sample size. Furthermore, a number of the L5 
genomes did not have data on ethnicity and hence affected the number of L5 isolated from patients of the Ewe 
ethnicity for which we used average estimates of 10 random samples of L5 isolated from patients of non-Ewe ori-
gin in comparisons to account for the different sample sizes. In addition, the observed differential diversities of L5 
and L6 could be due to founder effects of the lineages in Ghana which would require further studies comprising 
of Maf L5 and L6 from other West African countries pooled together for a sub-region-wide analysis.
In conclusion, our findings indicate that the two Maf lineages L5 and L6 are distinct in terms of population 
genomic diversity, and selection pressure on T cell epitopes and regulatory proteins, possibly reflecting different 
ecological niches. Whereas L5 may be maintained in West Africa by its co-evolution or adaptation with native 
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West Africans, L6 may be maintained by an unknown environmental reservoir, possibly a zoonotic source. This 
genomic analysis of Maf from Ghana gives a glimpse of the often neglected diversity within Maf and the MTBC 
overall. Further studies using representative genomes of Maf from across West Africa to describe the full diversity 
of these members of the MTBC as well as functional assays are required to better understand the biology of Maf. 
Improved knowledge of Maf will have implications for our understanding of human TB and the development of 
better control tools.
Methods
Ethical Statement and Participant Enrollment. The study and its protocols were reviewed by the 
Scientific and Technical Committee (STC) and approved by the Institutional Review Board (IRB) of the Noguchi 
Memorial Institute for Medical Research (NMIMR), Legon-Ghana with Federal Wide Assurance number 
FWA00001824. All study methods were performed in accordance with the guidelines and regulations of the STC 
and IRB of the NMIMR.
Mycobacterium africanum Strains. Isolates used for this study were cultivated from a population based 
study running from July 2007 to November 2014 in Ghana9,12, West Africa, involving consecutive sputum smear 
positive pulmonary TB cases recruited from three geographical regions of Ghana (two from the South and one 
from the North) as shown in the map (Supplementary Fig. S2) constructed with the ArcGIS ArcMap tool ESRI 
version 10.2.2 (https://support.esri.com/en/Products/Desktop/arcgis-desktop/arcmap/10-2-2). An oral/written 
informed consent was sought from illiterate/literate TB patients before enrolment unto the studies. For children 
below 18 years, informed consent from a parent and/or legal guardian before enrolment.
Mycobacterial Sub-Culturing and Chromosomal DNA Extraction. Mycobacterium africanum strains 
were revived by sub-culturing on Lowenstein Jensen (LJ) slants; one supplemented with 0.4% sodium pyruvate 
the other with glycerol to enhance the growth of Lineage 5 and Lineage 6 strains of respectively. The cultures were 
incubated at 37 °C and monitored regularly until growth was observed. When confluence was achieved, five loops 
full of colonies were fetched into 2 mL cryo-vials containing 1 mL of sterile nuclease-free water, heat-inactivated 
at 98 °C for 60 minutes for DNA extraction using a hybrid DNA extraction protocol42. The isolates were con-
firmed MTBC by PCR amplification of IS6110, genotyped as Maf by large sequence polymorphism (LSPs) 
detecting region of difference (RD) 9 and 1243. Lineage identification was achieved by spoligotyping as previ-
ously described44. Strains confirmed as belonging either L5 or L6 were sequenced by the illumina platform at the 
Wellcome Trust Sanger Institute, United Kingdom.
DNA Sequencing, Mapping of Sequence Reads, Variance Calling and Generation of Whole Genome 
Fasta files. Samples were sequenced as multiplexed libraries on the Illumina HiSeq platform to produce 
paired end reads of 125 nt in length. Genomes provided by the Research Center Borstel was obtained by sequenc-
ing DNA libraries prepared with the Nextera XT kit and run on Illumina MiSeq (250 and 300 bp, paired end) and 
NextSeq (150 bp, paired end) according to the manufacturer’s instruction (Illumina, San Diego, USA). The FastQ 
files containing the raw paired-end reads were processed using a python pipeline developed in house as follows. 
The reads were first adapter- and quality- trimmed with Trimmomatic v0.3345. Reads lower than 20 bp were 
not kept for the downstream analysis. Overlapping paired-end reads were then merged with SeqPrep (https://
github.com/jstjohn/SeqPrep). The resulting filtered reads were mapped to a hypothetical reconstructed MTBC 
ancestor32 with BWA v0.7.1246. Duplicated reads were marked by the MarkDuplicates module of Picard v 2.1.1 
(https://github.com/broadinstitute/picard). The RealignerTargetCreator and IndelRealigner modules of GATK 
v.3.4.0 (https://software.broadinstitute.org/gatk/download/archive) were used to perform local realignment of 
reads around indels. SNPs were called with Samtools v1.2 (https://sourceforge.net/projects/samtools/files/sam-
tools/1.2/) and VarScan v2.4.147 using the following thresholds: minimum mapping quality of 20, minimum base 
quality at a position of 20 and minimum read depth at a position of 7X. SNPs were considered fixed at a frequency 
of ≥90% and alleles were considered ancestral when the SNP frequency was ≤10%. Furthermore, SNPs were 
called only if the alternative basecall was supported by at least five reads and without strand bias. All variants were 
annotated using snpEff v4.1148, in accordance with the M. tuberculosis H37Rv reference annotation (AL123456.3). 
SNPs falling in regions with at least 50 bp identity to other regions in the genome were excluded from the analysis.
Generation of Variable Positions and Phylogenetic Analysis. The variable SNPs alignment was 
obtained by concatenating the SNP calls present in the variant calling file of each genome, using the IUPAC nucle-
otide ambiguity codes for heterozygous calls. A position was considered variable if at least one genome had a SNP 
at that position. Called deletions and positions not called according to the minimum threshold of 7 were encoded 
as gaps. Positions for which the proportion of gaps exceeded 50% were excluded from the alignment. Maximum 
likelihood phylogeny of the variable positions with 1000 bootstraps was then generated using RAxML version 
8.2.349 with GTR substitution matrix and other default settings with the final tree evaluated and optimized under 
GAMMA with accuracy of 0.1 Log likelihood units. The best tree was then, rooted on M. canettii and annotated 
using figtree (http://www.webcitation.org/getfile?fileid=27177ee8dd2f34cfd254b9c5e6c6fdf4b65329f6).
Comparative genomics analysis of isolates using genes encoding proteins of 8 functional categories. 
Experimentally confirmed human MTBC T cell epitope (1,226 epitopes) sequences (spanning 304 antigens with 
some overlapping sequences) retrieved from the Immune Epitope Database (IEDB), tested in human T cell assays, 
with no major histocompatibility complex (MHC) restrictions and have genomic coordinates in the H37Rv ref-
erence strain8,31 were in silico extracted from the fasta whole genome files and concatenated excluding sequence 
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redundancy using customized bash algorithms. Complementary sequences of epitopes encoded by the reversed 
strand were first transcribed before the concatenation to have all the sequences in the same direction. In addition, 
MTBC genes of other seven functional categories namely those encoding regulatory proteins (regprot; 196), genes 
involved with lipid metabolism (limpet; 267), genes involved with intermediate metabolism (intmedres; 917), 
genes involved with virulence, detoxification and adaptation (virdetad; 216), genes involved with information 
pathways (infopath; 234), genes involved with cell wall and cell processes (cwallproc; 768) and genes essential for 
growth in macrophages (esmac; 125) according to the tuberculist database50 were also retrieved and concatenated 
as described above excluding genes involved with drug resistance.
Estimation of Pairwise Nucleotide Diversity. Pairwise SNP distances of the whole genome excluding 
sites associated with drug resistance, concatenates of T cell epitopes and the genes of other seven functional cat-
egories were calculated with the dna.dist function of ape package51 of R version 3.2.352 as previously described8. 
Average pairwise nucleotide diversity per site (π) and confidence intervals for the π was calculated as previously 
described8 and plotted with ggplot2 package implemented in R. The upper and lower levels of confidence were 
attained by estimating the 97.5th and 2.5th quantiles of the π distribution obtained by bootstrapping (1000 repli-
cates) as previously described8. Non-overlapping confidence intervals of π were taken as evidence of statistically 
significant differences53,54. Details of the algorithm for this analysis are available upon request.
Estimation of Pairwise dN/dS. The concatenates of the human T cell epitopes and the other genes of 
seven functional categories were also used for estimation of dN/dS ratios stratified by lineage. As a follow up, 
dN/dS of T cell epitopes and regulatory proteins were also estimated for 15 L5 genomes from Ewe TB patients 
and 77 from non-Ewe TB patients. The dN/dS estimates were calculated with all polymorphic sites within each 
lineage using the kaks function of the seqinr packgage55 as previously described8 and box plotted using ggplot2 
package in in R version 3.2.3. Statistical difference of the estimates between the Maf lineages was accessed using 
the non-parametric Wilcoxon rank-sum tests with continuity correction in R version 3.4.0.
Human T cell Epitopes with Non-Synonymous SNPs and Count of Non-Redundant SNPs. 
Synonymous and non-synonymous mutations within the coordinates of each epitope were extracted from the var-
iant calling file (VCF) obtained for each genome. The specific human T cell epitopes with non-synonymous SNPs 
were compared between the Maf lineages for lineage-specific mutated epitopes and Maf-specific mutated epitopes.
Furthermore, the number of pairwise non-redundant SNPs was estimated for the Maf lineages (67 L6 genomes 
and the 10 random samples of L5 of equal size as L6) as well as L5 genomes stratified by patient ethnicity (15 L5 
from Ewe patients and 10 random samples of L5 from non-Ewe TB patients of size 15) using Mega656. The num-
ber of SNPs per each group was plotted and compared between the groups using the fisher’s exact test for statisti-
cal significance in R version 3.2.3.
Data availability. All the analyzed and/or generated data in this study are included in this article and its 
supplementary information files. Whole genome sequence reads have been submitted to the EMBL-EBI European 
Nucleotide Archive (ENA) Sequence Read Archive (SRA) with accession numbers provided in the supplementary 
document attached (Supplementary Data S8).
References
 1. Gagneux, S. et al. Variable host-pathogen compatibility in Mycobacterium tuberculosis. Proc. Natl. Acad. Sci. USA 103, 2869–2873 
(2006).
 2. Gagneux, S. & Small, P. M. Global phylogeography of Mycobacterium tuberculosis and implications for tuberculosis product 
development. Lancet Infect. Dis. 7, 328–37 (2007).
 3. Castets, M., Boisvert, H., Grumbach, F., Brunel, M. & Rist, N. Tuberculosis bacilli of the African type: preliminary note. Rev. Tuberc. 
Pneumol. (Paris). 32, 179–84 (1968).
 4. de Jong, B. C., Antonio, M. & Gagneux, S. Mycobacterium africanum-review of an important cause of human tuberculosis in 
WestAfrica. . PLoS Negl. Trop. Dis. 4, e744 (2010).
 5. Comas, I. et al. Out-of-Africa migration and Neolithic coexpansion of Mycobacterium tuberculosis with modern humans. Nat. 
Genet. 45, 1176–82 (2013).
 6. Comas, I. et al. Population Genomics of Mycobacterium tuberculosis in Ethiopia Contradicts the Virgin Soil Hypothesis for Human 
Tuberculosis in Sub-Saharan Africa. Curr. Biol. 3260–3266, https://doi.org/10.1016/j.cub.2015.10.061 (2015).
 7. Hershberg, R. et al. High functional diversity in Mycobacterium tuberculosis driven by genetic drift and human demography. PLoS 
Biol. 6, e311 (2008).
 8. Stucki, D. et al. Mycobacterium tuberculosis lineage 4 comprises globally distributed and geographically restricted sublineages. Nat. 
Genet. 48, 1535–1543 (2016).
 9. Asante-Poku, A. et al. Molecular epidemiology of Mycobacterium africanum in Ghana. BMC Infect. Dis. 16, 385 (2016).
 10. Yeboah-manu, D. et al. Genotypic diversity and drug susceptibility patterns among M. tuberculosis complex isolates from South-
Western Ghana. PLoS One 6, e21906 (2011).
 11. Bold, T. D. et al. Impaired fitness of Mycobacterium africanum despite secretion of ESAT-6. J. Infect. Dis. 205, 984–90 (2012).
 12. Asante-Poku, A. et al. Mycobacterium africanum Is Associated with Patient Ethnicity in Ghana. PLoS Negl. Trop. Dis. 9, e3370 
(2015).
 13. de Jong, B. C. et al. Progression to active tuberculosis, but not transmission, varies by Mycobacterium tuberculosis lineage in The 
Gambia. J. Infect. Dis. 198, 1037–43 (2008).
 14. Homolka, S., Niemann, S., Russell, D. G. & Rohde, K. H. Functional genetic diversity among Mycobacterium tuberculosis complex 
clinical isolates: delineation of conserved core and lineage-specific transcriptomes during intracellular survival. PLoS Pathog. 6, 
e1000988 (2010).
 15. Tientcheu, L. D. et al. Differences in T-cell responses between Mycobacterium tuberculosis and Mycobacterium africanum -infected 
patients. Eur. J. Immunol. 44, 1387–1398 (2014).
 16. Jong, B. C. D. et al. Mycobacterium africanum elicits an attenuated T cell response to early secreted antigenic target, 6 kDa, in 
patients with tuberculosis and their household contacts. J. Infect. Dis. 193, 1279–86 (2006).
www.nature.com/scientificreports/
1 0SCIENTIfIC RepoRtS |  (2018) 8:11269  | DOI:10.1038/s41598-018-29620-2
 17. Portevin, D. et al. Human macrophage responses to clinical isolates from the Mycobacterium tuberculosis complex discriminate 
between ancient and modern lineages. PLoS Pathog. 7, e1001307 (2011).
 18. Niemann, S., Merker, M., Kohl, T. & Supply, P. Impact of Genetic Diversity on the Biology of Mycobacterium tuberculosis Complex 
Strains. Microbiol. Spectr. 4 (2016).
 19. Källenius, G. et al. Evolution and clonal traits of Mycobacterium tuberculosis complex in Guinea-Bissau. J. Clin. Microbiol. 37, 
3872–3878 (1999).
 20. Niobe-Eyangoh, S. N. et al. Genetic biodiversity of Mycobacterium tuberculosis complex strains from patients with pulmonary 
tuberculosis in Cameroon. J. Clin. Microbiol. 41, 2547–53 (2003).
 21. Dosso, M. et al. Primary resistance to antituberculosis drugs: a national survey conducted in Côte d’Ivoire in 1995–1996* for the 
Ivoirian Study Group on Tuberculosis Resistance ** Projet Santé Abidjan Coopération Summary. Int J Tuberc Lung Dis 3, 805–809 
(1999).
 22. Koro, F. K. et al. Population dynamics of tuberculous bacilli in cameroon as assessed by spoligotyping. J. Clin. Microbiol. 51, 299–302 
(2013).
 23. Gehre, F. et al. The first phylogeographic population structure and analysis of transmission dynamics of M. africanum West African 
1–combining molecular data from Benin, Nigeria and Sierra Leone. PLoS One 8, e77000 (2013).
 24. Lawson, L. et al. A molecular epidemiological and genetic diversity study of tuberculosis in Ibadan, Nnewi and Abuja, Nigeria. PLoS 
One 7, e38409 (2012).
 25. Yeboah-Manu, D. et al. Spatio-Temporal Distribution of Mycobacterium tuberculosis Complex Strains in Ghana. PLoS One 11, 
e0161892 (2016).
 26. Vita, R. et al. The immune epitope database (IEDB) 3.0. Nucleic Acids Res. 43 (2015).
 27. Bos, K. I. et al. Pre-Columbian mycobacterial genomes reveal seals as a source of New World human tuberculosis. Nature 514, 
494–497 (2014).
 28. Kay, G. L. et al. Eighteenth-century genomes show that mixed infections were common at time of peak tuberculosis in Europe. Nat. 
Commun. 6, 6717 (2015).
 29. Brosch, R. et al. A new evolutionary scenario for the Mycobacterium. Proc. Natl. Acad. Sci. 99, 3684–3689 (2002).
 30. Mostowy, S., Cousins, D., Brinkman, J., Aranaz, A. & Behr, M. A. Genomic deletions suggest a phylogeny for the Mycobacterium 
tuberculosis complex. J. Infect. Dis. 186, 74–80 (2002).
 31. Coscolla, M. & Gagneux, S. Consequences of genomic diversity in mycobacterium tuberculosis. Semin. Immunol. 26, 431–444 
(2014).
 32. Comas, I. et al. Human T cell epitopes of Mycobacterium tuberculosis are evolutionarily hyperconserved. Nat. Genet. 42, 498–503 
(2010).
 33. Coscolla, M. et al. M. tuberculosis T Cell Epitope Analysis Reveals Paucity of Antigenic Variation and Identifies Rare Variable TB 
Antigens Reveals Paucity of Antigenic Variation and Identifies Rare Variable TB Antigens. Cell Host Microbe 18, 538–548 (2015).
 34. Pai, M. et al. Tuberculosis. Nat. Rev. Dis. Prim. 2, 16076 (2016).
 35. Brodin, P., Rosenkrands, I., Andersen, P., Cole, S. T. & Brosch, R. ESAT-6 proteins: Protective antigens and virulence factors? Trends 
Microbiol. 12, 500–508 (2004).
 36. Bigi, M. M. et al. Polymorphisms of 20 regulatory proteins between Mycobacterium tuberculosis and Mycobacterium bovis. 
Microbiol. Immunol., https://doi.org/10.1111/1348-0421.12402 (2016).
 37. Raman, S., Hazra, R., Dascher, C. C. & Husson, R. N. Transcription regulation by the Mycobacterium tuberculosis alternative sigma 
factor SigD and its role in virulence. J. Bacteriol., https://doi.org/10.1128/JB.186.19.6605-6616.2004 (2004).
 38. Gonzalo-asensio, J., Malaga, W., Pawlik, A. & Astarie-dequeker, C. Evolutionary history of tuberculosis shaped by conserved 
mutations in the PhoPR virulence regulator. 111 (2014).
 39. Peirs, P., Parmentier, B., De Wit, L. & Content, J. The Mycobacterium bovis homologous protein of the Mycobacterium tuberculosis 
serine/threonine protein kinase Mbk (PknD) is truncated. FEMS Microbiol. Lett. 188, 135–9 (2000).
 40. Saïd-Salim, B., Mostowy, S., Kristof, A. S. & Behr, M. A. Mutations in Mycobacterium tuberculosis Rv0444c, the gene encoding anti-
SigK, explain high level expression of MPB70 and MPB83 in Mycobacterium bovis. Mol. Microbiol. 62, 1251–1263 (2006).
 41. de Jong, B. C. et al. Differences between tuberculosis cases infected with Mycobacterium africanum, West African type 2, relative to 
Euro-American Mycobacterium tuberculosis: an update. FEMS Immunol. Med. Microbiol. 58, 102–5 (2010).
 42. Otchere, I. D. et al. Detection and characterization of drug-resistant conferring genes in Mycobacterium tuberculosis complex 
strains: A prospective study in two distant regions of. Tuberculosis (Edinb). 99, 147–154 (2016).
 43. Warren, R. M. et al. Molecular evolution of Mycobacterium tuberculosis: phylogenetic reconstruction of clonal expansion. 
Tuberculosis 81, 291–302 (2001).
 44. Kamerbeek, J. et al. Simultaneous detection and strain differentiation of Mycobacterium tuberculosis for diagnosis and 
epidemiology. J. Clin. Microbiol. 35, 907–14 (1997).
 45. Bolger, A. M., Lohse, M. & Usadel, B. Trimmomatic: A flexible trimmer for Illumina sequence data. Bioinformatics 30, 2114–2120 
(2014).
 46. Li, H. & Durbin, R. Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics 25, 1754–1760 (2009).
 47. Koboldt, D. C. et al. VarScan 2: Somatic mutation and copy number alteration discovery in cancer by exome sequencing VarScan 2: 
Somatic mutation and copy number alteration discovery in cancer by exome sequencing. Genome Res. 22, 568–576 (2012).
 48. Cingolani, P. et al. A program for annotating and predicting the effects of single nucleotide polymorphisms, SnpEff: SNPs in the 
genome of Drosophila melanogaster strainw1118; iso-2; iso-3. Fly (Austin). 6, 80–92 (2012).
 49. Stamatakis, A. RAxML version 8: A tool for phylogenetic analysis and post-analysis of large phylogenies. Bioinformatics 30, 
1312–1313 (2014).
 50. Lew, J. M., Kapopoulou, A., Jones, L. M. & Cole, S. T. TubercuList - 10 years after. Tuberculosis (Edinb). 91, 1–7 (2011).
 51. Popescu, A.-A., Huber, K. T. & Paradis, E. ape 3.0: New tools for distance-based phylogenetics and evolutionary analysis in R. 
Bioinformatics 28, 1536–1537 (2012).
 52. R Core Team. R: A language and environment for statistical computing version 3.2.3. R Foundation for Statistical Computing, Vienna, 
Austria (2015). Available at: https://www.coursehero.com/file/pe12cv/Code-R-version-323-2015-12-10-Wooden-Christmas-Tree-
Copyright-C-2015-The-R/. (Accessed: 26th July 2017).
 53. Gardner, M. J. & Altman, D. G. Statistics in Medicine Confidence intervals rather than P values: estimation rather than hypothesis 
testing. Br. Med. J. (Clin. Res. Ed). 292, 746–750 (1986).
 54. Nakagawa, S. & Cuthill, I. C. Effect size, confidence interval and statistical significance: A practical guide for biologists. Biol. Rev. 82, 
591–605 (2007).
 55. Charif, D. & Lobry, J. R. SeqinR 1.0-2: a contributed package to the R-project for statistical computing devoted to biological sequences 
retrieval and analysis. In: Bastolla U, Porto MERH, Vendruscolo M, editors. Structural approaches to sequence evolution: Molecules, 
networks, populations. Springer Verlag (2007).
 56. Tamura, K., Stecher, G., Peterson, D., Filipski, A. & Kumar, S. MEGA6: Molecular Evolutionary Genetics Analysis version 6.0. Mol. 
Biol. Evol. 30, 2725–9 (2013).
www.nature.com/scientificreports/
1 1SCIENTIfIC RepoRtS |  (2018) 8:11269  | DOI:10.1038/s41598-018-29620-2
Acknowledgements
Bacterial Isolation and DNA preparations were done in the Biosafety level 3 facility at the Noguchi Memorial 
Institute for Medical Research, University of Ghana. Bioinformatics analyses were performed using the 
scientific computing core (sciCORE) at the University of Basel and the computing facility of the Wellcome Trust 
Sanger Institute, Genome Campus, Cambridge University. This work was supported by the Wellcome Trust 
Intermediate Fellowship awarded to DYM (Grant Number 097134/Z/11/Z) and by the Swiss National Science 
Foundation (grants 310030_166687, IZRJZ3_164171 and IZLSZ3_170834), the European Research Council 
(309540-EVODRTB) and SystemsX.ch.
Author Contributions
Conceived the idea: D.Y.M., S.G. Designed experiments: D.Y.M., S.G., I.D.O., M.C., S.R.H., J.P. Contributed 
reagents and performed experiments: I.D.O., M.C., A.A.P., L.S.B., M.C., S.O.W., A.F., C.L., G.A.A., A.I.Y., A.B., 
S.Y.A., P.A., C.L., D.B., S.B., F.G., P.B., T.K., S.N., M.A., S.N., C.B., B.C.d.J., J.P. and S.R.H. Analysed Data: I.D.O., 
M.D.C., S.R.H., L.S.B., S.G., D.Y.M. Wrote manuscript: I.D.O., M.C., S.G. and D.Y.M. All authors critically 
reviewed the manuscript.
Additional Information
Supplementary information accompanies this paper at https://doi.org/10.1038/s41598-018-29620-2.
Competing Interests: The authors declare no competing interests.
Publisher's note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and 
institutional affiliations.
Open Access This article is licensed under a Creative Commons Attribution 4.0 International 
License, which permits use, sharing, adaptation, distribution and reproduction in any medium or 
format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Cre-
ative Commons license, and indicate if changes were made. The images or other third party material in this 
article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the 
material. If material is not included in the article’s Creative Commons license and your intended use is not per-
mitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the 
copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
 
© The Author(s) 2018
